Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | PIM1 | P11309 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 5/20 | 0.63 |
| ▸ | CA9 | Q16790 | 5/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.55 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.53 |
| ▸ | HSD17B3 | P37058 | 4/20 | 0.53 |
| ▸ | MAOA | P21397 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 2/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419327 | 0.84 | ALDH1A1 (1.00) | KDM4EKMT2AALDH1A1CA12CA9 | |
| SCHEMBL958685 | 0.84 | ALDH1A1 (1.00) | KDM4EKMT2AALDH1A1CA12CA9 | |
| Water SCHEMBL11848480 | 0.82 | ALDH1A1 (0.96) | KDM4EKMT2AALDH1A1CA12CA9 | |
| SCHEMBL128001 | 0.81 | KDM4E (0.74) | KDM4EKMT2AALDH1A1CA12CA9 | |
| SCHEMBL2490464 | 0.81 | PIM1 (0.64) | KDM4EKMT2AALDH1A1PIM1CA12 | |
| SCHEMBL10793717 | 0.81 | KDM4E (0.53) | KDM4EKMT2AALDH1A1PIM1CA12 | |
| SCHEMBL2761544 | 0.81 | PIM1 (1.00) | KDM4EKMT2AALDH1A1PIM1CA12 | |
| SCHEMBL10792023 | 0.81 | KDM4E (0.53) | KDM4EKMT2AALDH1A1PIM1CA12 | |
| SCHEMBL10795669 | 0.81 | PIM1 (0.54) | KDM4EKMT2AALDH1A1PIM1CA12 | |
| SCHEMBL5336545 | 0.81 | PIM1 (0.64) | KDM4EKMT2AALDH1A1PIM1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117721161-A | Biological-based multifunctional anti-aging auxiliary agent, and preparation method and application thereof | 四川大学 | 2024-03-19 | — | — | CN | claimed |
| CN-108598533-B | Coumarin-based photocyclization crosslinking sulfonated polyimide proton exchange membrane and preparation method thereof | 同济大学 | 2020-11-03 | — | — | CN | claimed |
| CN-108598533-A | Cyclization cross-linked polyimide proton exchange membrane based on cumarin and preparation method thereof | 同济大学 | 2018-09-28 | — | — | CN | claimed |
| CN-118834490-A | Photo-crosslinkable perfluorinated ion membrane and preparation method thereof | 上海交通大学 | 2024-10-25 | — | — | CN | disclosed |
| CN-117721161-A | Biological-based multifunctional anti-aging auxiliary agent, and preparation method and application thereof | 四川大学 | 2024-03-19 | — | — | CN | disclosed |
| EP-4317284-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | Daikin Industries, Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20240034856-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-01 | — | — | US | disclosed |
| CN-117043260-A | Composition for cross-linking fluororubber and molded article | 大金工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022210044-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | ダイキン工業株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-11141402-B2 | Compounds useful in inhibiting human trefoil factor 3 | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2021-10-12 | — | — | US | disclosed |
| EP-3848367-A1 | TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2021-07-14 | — | — | EP | disclosed |
| CN-1254338-A | Process for preparing photoactive coumarin derivatives | HOECHST CELANESE CORP (CH) | 2000-05-24 | — | — | CN | disclosed |
| EP-0977747-A1 | PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 2000-02-09 | — | — | EP | disclosed |
| EP-0968202-A1 | PROCESS FOR PREPARING PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 2000-01-05 | — | — | EP | disclosed |
| EP-0950655-A1 | AMINOMETHYLENE DERIVATIVES AND ULTRAVIOLET ABSORBER COMPRISING THE SAME | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998039317-A1 | PROCESS FOR PREPARING PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 1998-09-11 | — | — | WO | disclosed |
| WO-1998039319-A1 | PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 1998-09-11 | — | — | WO | disclosed |
| EP-0442655-B1 | Benzisoxazole derivatives | ZENECA LTD (GB) | 1996-01-17 | — | — | EP | disclosed |
| US-5176737-A | BENZISOXAZOLE COMPOUNDS USEFUL AS HERBICIDES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-01-05 | — | — | US | disclosed |
| EP-0442655-A2 | Benzisoxazole derivatives | ZENECA LIMITED (GB) | 1991-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11141402-B2 | Compounds useful in inhibiting human trefoil factor 3 | ETF1, F3, DNASE1L3 | KDM4E 3966/4885KMT2A 4155/4885ALDH1A1 3051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.